KUALA LUMPUR, Malaysia,&nbsp;April 5, 2023-Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&amp;D, manufacturing and sale of innovative medications, today announced that it has entered an agreement with Duopharma Marketing Sdn Bhd, a wholly-owned subsidiary of Duopharma Biotech Berhad (Duopharma Biotech), which grants the latter exclusive marketing and distribution rights to a cholesterol management product in&nbsp;Malaysia.

<a href="https://mma.prnasia.com/media2/2048093/Picture1.jpg?p=publish" target="_blank" rel="nofollow"></a>Luye Pharma and Duopharma Biotech Strategic Partnership Signing Ceremony

Developed by Luye Pharma, the product is a traditional Chinese medicine made by using modern technology to ferment special red yeast rice, a natural alternative for cholesterol management.&nbsp;

Through this partnership, Luye Pharma will be able to leverage Duopharma Biotech's long-term expertise in the cardiovascular therapeutic field, both in terms of its excellent promotion in academic and extensive distribution network throughout clinics and hospitals, further expanding the accessibility of the product in&nbsp;Malaysia. The two companies expect that the product will grow at a compound annual growth rate of double digits in the local market over the next 10 years.

Andy Siow, APAC Regional Director of Luye Pharma (International) said: "The product's efficacy has been widely recognized by doctors and patients over long-term clinical use in&nbsp;Malaysia. The partnership with Duopharma Biotech will enable this highly trusted and naturally produced traditional Chinese medicine to reach more patients in need."

"This partnership and collaboration with Luye Pharma enables all patients in&nbsp;Malaysia&nbsp;to have choices in the therapies and medications they need for their well-being." said Leonard Ariff&nbsp;Abdul&nbsp;Shatar, Group&nbsp;Managing&nbsp;Director,&nbsp;Duopharma&nbsp;Biotech&nbsp;Berhad.

Luye Pharma Group (Luye Pharma) is an international pharmaceutical company dedicated to the R&amp;D, manufacturing and sale of innovative medications. The company has established R&amp;D centers in&nbsp;China, the U.S. and&nbsp;Europe, with a robust pipeline of over 30 drug candidates in&nbsp;China&nbsp;and more than 10 drug candidates in other international markets. Luye Pharma maintains high-level international standards in novel drug delivery technologies including microspheres, liposomes, and transdermal drug delivery systems. The company has also achieved multiple innovations in new chemical entities and antibodies, and is actively making strategic developments in the fields of cell therapies and gene therapies.

Luye Pharma is developing a global supply chain of 8 manufacturing sites with over 30 production lines in total, establishing GMP quality management and international standard control systems. With more than 30 products covering the central nervous system, oncology, cardiovascular, metabolism and other therapeutic areas, business is conducted in over 80 countries and regions around the world, including the largest pharmaceutical markets -&nbsp;China, the U.S.,&nbsp;Europe&nbsp;and&nbsp;Japan, as well as in fast growing emerging markets.

For more information, please visit:&nbsp;<a href="http://www.luye.cn/lvye_en" target="_blank" rel="nofollow">www.luye.cn/lvye_en</a>

Duopharma Biotech Group ("Duopharma Biotech" or "the Company") began with the establishment of Duopharma (M) Sendirian Berhad in 1978. Duopharma Biotech was incorporated in 2000 and is today one of&nbsp;Malaysia's&nbsp;leading pharmaceutical companies listed on the Main Market of Bursa Malaysia Berhad. &nbsp;

Duopharma Biotech has core competencies in the pharmaceutical industry inclusive of Manufacturing, Research &amp; Development and Commercialisation &amp; Marketing of over 300 generic drugs such as Crystorvas, Prelica and Omesec as well as Consumer Healthcare ("CHC") products including CHAMPS®, FLAVETTES®, PROVITON®&nbsp;and Uphamol, which are well-recognised and accepted by consumers in&nbsp;Malaysia, regionally and globally. The Company has also diversified into the biosimilars space with technology and commercialisation collaborations with credible and strong international partners. ERYSAA®, Basalog One®, and Zuhera are a few commercialised biosimilar brands.

Headquartered in&nbsp;Kuala Lumpur, Malaysia, Duopharma Biotech owns and operates three manufacturing plants in Klang, Bangi and Glenmarie,&nbsp;Selangor. Duopharma Biotech also has subsidiary companies in&nbsp;the Philippines&nbsp;and&nbsp;Singapore. A subsidiary of Duopharma Biotech Berhad has a representative office in&nbsp;Jakarta, Indonesia.

Website:<a href="http://www.duopharmabiotech.com/" target="_blank" rel="nofollow">&nbsp;www.duopharmabiotech.com</a>

<h1>Luye Pharma and Duopharma Reach Strategic Partnership to Expand Accessibility of Cholesterol Management Products in Malaysia</h1>KUALA LUMPUR, Malaysia,&nbsp;April 5, 2023-Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&amp;D, manufacturing and sale of innovative medications, today announced that it has entered an agreement with Duopharma Marketing Sdn Bhd, a wholly-owned subsidiary of Duopharma Biotech Berhad (Duopharma Biotech), which grants the latter exclusive marketing and distribution rights to a cholesterol management product in&nbsp;Malaysia.<img style="max-width:100%;height:auto;" src="https://vritimes-public.s3.ap-southeast-1.amazonaws.com/production/Picture1.jpg" alt="Image"/><a href="https://mma.prnasia.com/media2/2048093/Picture1.jpg?p=publish" target="_blank" rel="nofollow"></a>Luye Pharma and Duopharma Biotech Strategic Partnership Signing CeremonyDeveloped by Luye Pharma, the product is a traditional Chinese medicine made by using modern technology to ferment special red yeast rice, a natural alternative for cholesterol management.&nbsp;Through this partnership, Luye Pharma will be able to leverage Duopharma Biotech's long-term expertise in the cardiovascular therapeutic field, both in terms of its excellent promotion in academic and extensive distribution network throughout clinics and hospitals, further expanding the accessibility of the product in&nbsp;Malaysia. The two companies expect that the product will grow at a compound annual growth rate of double digits in the local market over the next 10 years.Andy Siow, APAC Regional Director of Luye Pharma (International) said: "The product's efficacy has been widely recognized by doctors and patients over long-term clinical use in&nbsp;Malaysia. The partnership with Duopharma Biotech will enable this highly trusted and naturally produced traditional Chinese medicine to reach more patients in need.""This partnership and collaboration with Luye Pharma enables all patients in&nbsp;Malaysia&nbsp;to have choices in the therapies and medications they need for their well-being." said Leonard Ariff&nbsp;Abdul&nbsp;Shatar, Group&nbsp;Managing&nbsp;Director,&nbsp;Duopharma&nbsp;Biotech&nbsp;Berhad.About Luye Pharma GroupLuye Pharma Group (Luye Pharma) is an international pharmaceutical company dedicated to the R&amp;D, manufacturing and sale of innovative medications. The company has established R&amp;D centers in&nbsp;China, the U.S. and&nbsp;Europe, with a robust pipeline of over 30 drug candidates in&nbsp;China&nbsp;and more than 10 drug candidates in other international markets. Luye Pharma maintains high-level international standards in novel drug delivery technologies including microspheres, liposomes, and transdermal drug delivery systems. The company has also achieved multiple innovations in new chemical entities and antibodies, and is actively making strategic developments in the fields of cell therapies and gene therapies.Luye Pharma is developing a global supply chain of 8 manufacturing sites with over 30 production lines in total, establishing GMP quality management and international standard control systems. With more than 30 products covering the central nervous system, oncology, cardiovascular, metabolism and other therapeutic areas, business is conducted in over 80 countries and regions around the world, including the largest pharmaceutical markets -&nbsp;China, the U.S.,&nbsp;Europe&nbsp;and&nbsp;Japan, as well as in fast growing emerging markets.For more information, please visit:&nbsp;<a href="http://www.luye.cn/lvye_en" target="_blank" rel="nofollow">www.luye.cn/lvye_en</a>About Duopharma Biotech BerhadDuopharma Biotech Group ("Duopharma Biotech" or "the Company") began with the establishment of Duopharma (M) Sendirian Berhad in 1978. Duopharma Biotech was incorporated in 2000 and is today one of&nbsp;Malaysia's&nbsp;leading pharmaceutical companies listed on the Main Market of Bursa Malaysia Berhad. &nbsp;Duopharma Biotech has core competencies in the pharmaceutical industry inclusive of Manufacturing, Research &amp; Development and Commercialisation &amp; Marketing of over 300 generic drugs such as Crystorvas, Prelica and Omesec as well as Consumer Healthcare ("CHC") products including CHAMPS®, FLAVETTES®, PROVITON®&nbsp;and Uphamol, which are well-recognised and accepted by consumers in&nbsp;Malaysia, regionally and globally. The Company has also diversified into the biosimilars space with technology and commercialisation collaborations with credible and strong international partners. ERYSAA®, Basalog One®, and Zuhera are a few commercialised biosimilar brands.Headquartered in&nbsp;Kuala Lumpur, Malaysia, Duopharma Biotech owns and operates three manufacturing plants in Klang, Bangi and Glenmarie,&nbsp;Selangor. Duopharma Biotech also has subsidiary companies in&nbsp;the Philippines&nbsp;and&nbsp;Singapore. A subsidiary of Duopharma Biotech Berhad has a representative office in&nbsp;Jakarta, Indonesia.Website:<a href="http://www.duopharmabiotech.com/" target="_blank" rel="nofollow">&nbsp;www.duopharmabiotech.com</a>Source: Luye Pharma

Diet / Health food / Supplement

Medical / Hospital

Banks / Credit unions

Luye Pharma and Duopharma Reach Strategic Partnership to Expand Accessibility of Cholesterol Management Products in Malaysia

HR / Recruitment

Skin care / Cosmetics / Hair products

Internet service

Film / Drama

Magazines / Books / Publications

Marketing / Research

Childbirth / Childcare

Interior / Furniture / Storage

Mobile device

Servers / Peripherals

Network / Network Equipment

System / Website / Application development

Electronic components / Semiconductors / Electrical equipment

Department stores / Supermarkets / Convenience stores / Stores

Wholeseller

Manga / Anime

Arcade Game

Toys / Playsets / Dolls

Car / Car Supplies

Motorcycles / Motorcycle Supplies

Daily necessities / Household goods

Garden / DIY

Shoes / Bags

Jewelry / Accessories

Kids / Baby / Maternity

Food / Sweets

Soft Drinks / Alcoholic drinks

Restaurant / Fast food / Streetfood

Eating at home / Delivery

Fitness / Healthcare

Pharmaceuticals

Pets / Pet Supplies

Gifts / Flowers

Love / Marriage

Funeral

Hotels / inns

Travel / Sightseeing

Theme Park / Amusement park

Residential / Condominium

Commercial facilities / Office buildings

Architecture / Space design

Construction / Civil engineering

Advertising / Promotion / PR

Sales

Management Consulting

Think tank

Legal / Patent / Intellectual Property

Logistics / Warehouse / Cargo

Steel / Metal / Glass / Earth / Stone / Rubber

Chemistry

Electricity / Gas / Resources / Energy

Nature / Weather

School / University

Cram school / Preparatory school / Online education

Life insurance / Non-life insurance

Mobile app

Mobile games

Cooking / Home appliances

Health and Beauty appliances

Application

Ladies' Fashion

Men's Fashion

Accounting

Environment / SGDs / Recycling

International activity

Full time job / Part-time job / Career

E-commerce

Music

Internet Service Provider / Line connection

Camera

AV equipment

Consumer Games

Outdoors / Mountain Climbing

Welfare / Nursing / Rehabilitation

Qualifications / Study Abroad / Language

Childcare / Early childhood education

Credit card / Loan

Securities / FX / Investment Trusts

Moving

Politics / Government / Local government

Volunteer

Agriculture / Forestry / Fisheries

Bicycle / Bicycle Supplies

Female Related

Venture Capitals

Coaching / Mentoring / Consultation

Automotive / Motorcycle / Bicycle

Automotive / Automotive Supplies

Interior / Goods

Real Estate / Architecture / Construction

Software

Blockchain / Web3

Security

Telecommunications / VoIP

Show Business

Comedy

Health